Prosecution Insights
Last updated: April 19, 2026
Application No. 18/303,684

GLENOID IMPLANT FOR REVERSE SHOULDER PROSTHESIS

Non-Final OA §102§103§112
Filed
Apr 20, 2023
Examiner
HU, ANN M
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Fx Solutions
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
3y 10m
To Grant
89%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allow Rate
631 granted / 932 resolved
-2.3% vs TC avg
Strong +21% interview lift
Without
With
+20.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
55 currently pending
Career history
987
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
43.8%
+3.8% vs TC avg
§102
30.5%
-9.5% vs TC avg
§112
17.9%
-22.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 932 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I in the reply filed on 12/1/2025 is acknowledged. Claims 10-12 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 12/1/2025. The requirement is deemed proper and is therefore made FINAL. Claim Objections Claims 1 and 9 are objected to because of the following informalities: a misspelling of the term “comprising.” Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 3, 8, and their dependent claims are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1, lines 4-6, recite “the rod comprising through-holes, and by screws for anchoring the rod configured to cross radially the rod, via the through-holes, and the bone, when the glenoid implant is implanted on the bone.” Claim 8 recites “two stabilizing ends configured to extend each side of the bone when the glenoid implant is implanted on the bone.” This language has grammatical and idiomatic errors and does not clearly define the metes and bounds of the claims. Appropriate correction is required. Claim 1 recites the limitation "the thickness" in line 3. Claim 3 recites the limitation "the glenosphere" in line 2. There is insufficient antecedent basis for these limitations in the claims. Appropriate correction is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 and 3-9 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bonin et al. (WO 2014/075037 A1; hereinafter “Bonin”). Bonin discloses the following regarding claim 1: a glenoid implant for reverse shoulder prosthesis compring, a base (e.g., 112) for anchoring the implant to a bone formed by a rod (e.g., Figs. 3-4) configured to extend through the thickness of the bone from a glenoid fossa (Figs. 3-4), the rod comprising through-holes (114), and by screws (e.g., 130) for anchoring the rod configured to cross radially the rod (e.g., Figs. 3-4), via the through-holes, and the bone, when the glenoid implant is implanted on the bone (paras. 0005-0006, 0038-0039). Bonin discloses the following regarding claim 3: the glenoid implant according to claim 1, wherein the rod comprises a surface (e.g., 150) for receiving a spacer (e.g., 140) for attaching the rod to the glenosphere (paras. 0038-0039). Please note that a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Regarding claims 3 and 5, the spacer of Bonin is fully capable of attaching or connecting the rod to a glenosphere upon the full assembly of implant, as Bonin is designed to interact with a humeral head and/or a prosthetic implant (paras. 0005-0006, 0038). Bonin discloses the following regarding claim 4: the glenoid implant according to claim 3, wherein the receiving surface comprises a bore (central opening in element 150) configured to collaborate with the spacer (Fig. 4) and a groove (please see annotated Figure A, below) surrounding the bore (Fig. 4), the groove being configured to interact with a tool for gripping and guiding the rod. Please note that the groove of Bonin is fully capable of interacting with a tool when the spacer is not inserted. PNG media_image1.png 335 402 media_image1.png Greyscale Figure A. Bonin discloses the following regarding claim 5: the glenoid implant according to claim 3, wherein the spacer is formed by a first portion (lower, perimeter portion of element 140) for attaching the spacer to the rod (Fig. 4) and a second portion (upper, central portion) for attaching the spacer to the glenosphere, the first portion and the second portion being offset with respect to each other (Figs. 3-4). Bonin discloses the following regarding claim 6: the glenoid implant according to claim 5, wherein the first portion and the second portion are inclined with respect to each other (Figs. 3-4). Bonin discloses the following regarding claim 7: the glenoid according to claim 1, further comprising a part (e.g., 116) for stabilizing the glenoid implant with respect to the bone when the glenoid implant is implanted on the bone (para. 0038). Bonin discloses the following regarding claim 8: the glenoid according to claim 7, wherein the stabilizing part comprises two stabilizing ends (medial and lateral ends of element 116) configured to extend each side of the bone when the glenoid implant is implanted on the bone (Figs. 3-4). The claim language is being interpreted to mean that the stabilizing ends extend into a bone. Bonin discloses the following regarding claim 9: a reverse shoulder prosthesis compring a glenoid implant according to claim 1 (paras. 0005-0006, 0038-0039). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2 is/are rejected under 35 U.S.C. 103 as being unpatentable over Bonin in view of Lappin (Pub. No.: US 2013/0261750 A1). Bonin discloses the limitations of the claimed invention, as described above. It further recites that its glenoid implant articulates against a humeral head or a prosthetic implant (paras. 0005-0006, 0038). However, it does not explicitly recite that the prosthetic implant is a glenosphere. Lappin teaches that it is well known in the art that a shoulder implant comprises a glenoid device and a glenosphere (paras. 0004-0010, 0054), for the purpose of providing the patient with the desired shoulder motion and articulation. It would have been obvious to one having ordinary skill in the art to modify the device of Bonin to comprise a glenosphere, as taught by Lappin, in order to allow for the desired shoulder motion and articulation. Such a modification would be made with a reasonable expectation of success. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ann Hu whose telephone number is (571) 272-6652. The examiner can normally be reached on Monday-Friday (9:00 am-5:30 pm EST). If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Jerrah Edwards, at (408) 918-7557. The fax phone number for the organization where this application or proceeding is assigned is (571) 273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANN HU/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Apr 20, 2023
Application Filed
Dec 12, 2025
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551339
EXPANDABLE IMPLANTABLE CONDUIT
2y 5m to grant Granted Feb 17, 2026
Patent 12533249
ACUTE AND CHRONIC DEVICES FOR MODIFYING FLOW IN BODY LUMENS AND METHODS OF USE THEREOF
2y 5m to grant Granted Jan 27, 2026
Patent 12521241
TRANSCATHETER VALVE PROSTHESIS HAVING AN EXTERNAL SKIRT FOR SEALING AND PREVENTING PARAVALVULAR LEAKAGE
2y 5m to grant Granted Jan 13, 2026
Patent 12514701
Low Profile Expandable Heart Valve
2y 5m to grant Granted Jan 06, 2026
Patent 12502273
PERIVALVULAR SEALING FOR TRANSCATHETER HEART VALVE
2y 5m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
89%
With Interview (+20.9%)
3y 10m
Median Time to Grant
Low
PTA Risk
Based on 932 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month